DEF: Gabelli Healthcare & WellnessRx Trust Announces Annual Meeting of Shareholders

The Gabelli Healthcare & WellnessRx Trust will hold its Annual Meeting of Shareholders on May 12, 2025, to elect trustees and consider other business matters.

Summary

• The Gabelli Healthcare & WellnessRx Trust (the 'Fund') will hold its Annual Meeting of Shareholders on May 12, 2025.
• The meeting will take place at the Indian Harbor Yacht Club in Greenwich, Connecticut, and virtually via webcast.
• Shareholders will vote to elect two trustees, one elected by common and preferred shareholders voting together, and one elected by preferred shareholders voting separately.
• The record date for determining shareholders eligible to vote is March 13, 2025.
• Shareholders can vote by telephone, internet, or mail.
• The Fund has two classes of shares outstanding: common shares (15,498,074 shares) and preferred shares (3,036,500 Series E and 2,367,000 Series G).
• Saba Capital Management, L.P. owns 12.6% of the common shares, while GAMCO Investors, Inc. and affiliates own 54.7% of the preferred shares.
• The Board of Trustees consists of ten members, seven of whom are independent.
• James P. Conn and Jeffrey J. Jonas have been nominated for election to serve a three-year term expiring at the 2028 Annual Meeting.
• The Fund's most recent annual report, including audited financial statements for the fiscal year ended December 31, 2024, is available upon request.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The information is factual and procedural, with no significant positive or negative implications for the Fund's performance.

Positives

• The Fund provides multiple options for shareholders to vote (telephone, internet, mail).
• The Fund offers a hybrid meeting format, allowing both in-person and virtual attendance.
• The Board has a majority of independent trustees, ensuring strong oversight.
• The Audit Committee is composed entirely of independent trustees.
• The Fund provides clear instructions for shareholders to submit recommendations for trustee candidates.

Negatives

• The DSTA Control Share Statute could discourage third parties from seeking control over the Fund, potentially reducing market demand for common shares.
• The ownership restrictions set forth in the Funds Governing Documents and the limitations of the DSTA Control Share Statute could have the effect of increasing the likelihood that the Funds common shares trade at a discount to net asset value and increasing the amount of any such discount.

Risks

• The DSTA Control Share Statute could discourage potential acquirers, potentially limiting shareholder opportunities to sell shares at a premium.
• Uncertainty exists around the general application under the 1940 Act of state control share statutes as a result of recent court decisions.
• Enforcement of control share restrictions against beneficial owners who hold their shares through financial intermediaries may be uncertain.

Future Outlook

The Fund intends to hold its next Annual Meeting of Shareholders in 2026, with specific deadlines for shareholder proposals and nominations outlined in the proxy statement.

Industry Context

This is a standard proxy statement for a closed-end fund, outlining the governance and voting procedures for the upcoming annual meeting. The information provided is typical for registered investment companies.

Comparison to Industry Standards

• The structure of the Board with a majority of independent trustees aligns with industry best practices for closed-end funds.
• The detailed disclosures regarding trustee compensation and potential conflicts of interest are consistent with regulatory requirements and industry norms.
• The inclusion of the DSTA Control Share Statute discussion is specific to Delaware statutory trusts and reflects a proactive approach to addressing potential control share acquisitions, similar to other funds organized in Delaware.

Corporate Governance

Stakeholder Impact

• Shareholders are directly impacted by the election of trustees and other matters voted on at the Annual Meeting.
• The DSTA Control Share Statute could affect shareholders' ability to sell their shares at a premium in the event of a potential acquisition.

Next Steps

• Shareholders should review the proxy statement and vote on the proposals.
• Shareholders planning to attend the virtual meeting must register by May 11, 2025.
• The Fund will hold its Annual Meeting on May 12, 2025.
• The Fund will inform shareholders of the voting results in its Semiannual Report for the six months ended June 30, 2025.

Key Dates

Keywords

Annual Meeting, Shareholders, Trustees, Proxy Statement, Gabelli Healthcare & WellnessRx Trust, Voting, Preferred Shares, Common Shares, Board of Trustees, Investment Company